CRNX SCHEDULE 13G/A: SEC filing

Farallon Capital Management, L.L.C. and affiliated individuals

Filed with the SEC on Nov 12, 2026 · accession 0000908834-26-000520

CRNX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 12, 2026. Farallon Capital Management, L.L.C. and affiliated individuals filed an amended Schedule 13G indicating passive beneficial ownership of Crinetics Pharmaceuticals common stock as of September 30, 2026.

Summary of the filing

Farallon Capital Management, L.L.C. and affiliated individuals filed an amended Schedule 13G indicating passive beneficial ownership of Crinetics Pharmaceuticals common stock as of September 30, 2026. The filing reports no shares beneficially owned (0 shares, 0%) by the reporting persons.

For details, click here →

Key details

Shares beneficially owned$0

Percent of class beneficially ownedPCT 0

Filer / reporting personFarallon Capital Management, L.L.C.

Issuer / subject companyCrinetics Pharmaceuticals, Inc.

Managing member, farallon capital management, l.l.c.Hannah E. Dunn

Managing member, farallon capital managementJoshua J. Dapice

Managing member, farallon capital managementPhilip D. Dreyfuss

✦ Ask GOAX AI about this filing — what it means for CRNX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CRNX?

Click here

Frequently asked questions

What did CRNX file with the SEC on Nov 12, 2026?

CRNX filed a SCHEDULE 13G/A (SEC filing). Farallon Capital Management, L.L.C. and affiliated individuals filed an amended Schedule 13G indicating passive beneficial ownership of Crinetics Pharmaceuticals common stock as of September 30, 2026. The filing reports no shares beneficially owned (0 shares, 0%) by the reporting persons.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other CRNX SEC filings

Get alerts when CRNX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

CRNX overview CRNX analysis CRNX news Latest SEC filings